论文信息 - Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy - 字舞流文

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy

C. Rudd | R. Kremer | B. Larrivée | M. Issa | A. Kazanova | Janna Krueger | F. Santinon | C. Milhalcioiu | Mark E Issa | Catalin Milhalcioiu